Cerebral Infarction | "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"

Cerebral Infarction research study

What is the primary objective of this study?

The objective of this study is to better characterize the mechanisms of action of fluoxetine in motor recovery and more specifically to identify the neurophysiological substrate underlying fluoxetine-induced motor recovery in stroke. In this study, the investigators propose to use transcranial magnetic stimulation (TMS) to assess the effect of a chronic treatment of fluoxetine on corticospinal excitability and integrity.

Who is eligible to participate?

Inclusion Criteria: - Man and women, aged from 18 to 80 years. - Social security affiliation - Inclusion from day 3 to day 15 after stroke or brain haemorrhage - Hemiparesia with upper limb motor deficit (Fugl-Meyer score - hand < or = 10) - Informed consent Exclusion Criteria: - Score NIHSS > 20 - Depression (criteria DSM5-R) with MADRS score > 19 - History of recurrent bipolar or depressive disorders. - History of behavior or suicidal idea - Family history of extension of the interval QT or congenital long interval QT - History of clinical stroke - Aphasia preventing correct evaluation of motor and depression scales. - Patients treated by antidepressant drugs, monoamine oxidase inhibitor (IMAO), and neuroleptics in the past month - Benzodiazepines within 48 hours preceding inclusion. - Intolerance or allergy to fluoxetine (SandozĀ® 20 mg pill) - Severe swallowing disorders preventing oral administration of the treatment - Planned carotid surgery - Pregnant or breast-feeding woman - Hepatic failure (TGO and TGP >2N); severe renal failure (creatinine >180micromol/l) - Concomitant severe disease not allowing follow-up. - Participation to another therapeutic study. - Contraindication to MRI and TMS

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Cerebral Infarction

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Fluoxetine1 pill of 20mg / day, during 3 months

Drug:Placebo of fluoxetine1 pill of 20mg/day, during 3 months

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.



Study Status


Start Date: February 2014

Completed Date: August 2015

Phase: N/A

Type: Interventional


Primary Outcome: Slope of the curve of recruitment of the PEMs

Secondary Outcome: Slope of recruitment of the PEMs

Study sponsors, principal investigator, and references

Principal Investigator: Jean-Claude BARON, MD

Lead Sponsor: Centre Hospitalier St Anne


More information:

Discuss Prozac